Discontinued — last reported Q4 '25

Operating Expenses

Finance Lease ROU Asset Amortization

West Pharmaceutical Services Finance Lease ROU Asset Amortization remained flat by 0.0% to $500.00K in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 66.7%, from $300.00K to $500.00K.

Analysis

StatementIncome Statement
SectionOperating Expenses
CategoryEfficiency
SignalContext dependent
VolatilityStable
First reportedQ1 2019
Last reportedQ4 2025

How to read this metric

Changes reflect the company's strategy regarding capital asset acquisition versus leasing.

Detailed definition

This represents the non-cash expense related to the systematic write-down of right-of-use assets acquired through financ...

Peer comparison

Standard disclosure under ASC 842 lease accounting requirements.

Metric ID: msft_finance_lease_right_of_use_asset_amortization

Historical Data

9 periods
 Q2 '23Q3 '23Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26
Value$0.00$0.00$0.00$300.00K$300.00K$300.00K$400.00K$500.00K$500.00K
QoQ Change————+0.0%+0.0%+33.3%+25.0%+0.0%
YoY Change——————+33.3%+66.7%+66.7%
Range$0.00 – $500.00K
Avg YoY Growth+55.6%
Median YoY Growth+66.7%
Current Streak5+ quarters growth

Frequently Asked Questions

What is West Pharmaceutical Services's finance lease rou asset amortization?
West Pharmaceutical Services (WST) reported finance lease rou asset amortization of $500.00K in Q1 2026.
How has West Pharmaceutical Services's finance lease rou asset amortization changed year-over-year?
West Pharmaceutical Services's finance lease rou asset amortization increased by 66.7% year-over-year, from $300.00K to $500.00K.
What does finance lease rou asset amortization mean?
The periodic expense for the usage of assets held under finance leases.